NCT00207675View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

August 31, 2007

Conditions

Crohn Disease

Interventions

DRUG

infliximab

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Centocor BV

INDUSTRY

lead

Centocor, Inc.

INDUSTRY

NCT00207675 - A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter